NSE - Delayed Quote INR

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)

Compare
700.85 +28.40 (+4.22%)
At close: 3:30:00 PM GMT+5:30

Valuation Measures

Annual
Monthly
Currency in INR
Download
Current9/30/20246/30/20243/31/202412/31/20239/30/2023
Market Cap 17.91B 11.10B 8.91B 7.37B 10.19B 10.99B
Enterprise Value 17.22B 9.71B 7.88B 6.35B 9.17B 9.90B
Trailing P/E 74.72 54.95 36.36 29.77 36.04 35.15
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales 7.96 5.30 4.04 3.31 4.37 4.66
Price/Book 9.06 5.86 5.27 4.32 6.03 6.91
Enterprise Value/Revenue 7.59 4.65 3.57 2.88 3.92 4.18
Enterprise Value/EBITDA 46.09 30.06 22.48 18.10 23.20 27.28
9/30/2023 - 7/1/2002

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 3/31/2024
Most Recent Quarter (mrq) 9/30/2024

Profitability

Profit Margin 10.71%
Operating Margin (ttm) 18.67%

Management Effectiveness

Return on Assets (ttm) 6.05%
Return on Equity (ttm) 13.26%

Income Statement

Revenue (ttm) 2.27B
Revenue Per Share (ttm) 85.10
Quarterly Revenue Growth (yoy) 29.20%
Gross Profit (ttm) --
EBITDA 257.16M
Net Income Avi to Common (ttm) 243M
Diluted EPS (ttm) 9.01
Quarterly Earnings Growth (yoy) 53.40%

Balance Sheet

Total Cash (mrq) 778.45M
Total Cash Per Share (mrq) 29.39
Total Debt (mrq) 98.14M
Total Debt/Equity (mrq) 4.98%
Current Ratio (mrq) 2.95
Book Value Per Share (mrq) 74.42

Cash Flow Statement

Operating Cash Flow (ttm) 575.11M
Levered Free Cash Flow (ttm) 548.59M

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52 Week Range 3 68.22%
S&P 500 52-Week Change 3 27.65%
52 Week High 3 820.10
52 Week Low 3 273.60
50-Day Moving Average 3 565.77
200-Day Moving Average 3 403.65

Share Statistics

Avg Vol (3 month) 3 163.47k
Avg Vol (10 day) 3 175.78k
Shares Outstanding 5 26.55M
Implied Shares Outstanding 6 26.63M
Float 8 5.72M
% Held by Insiders 1 76.28%
% Held by Institutions 1 1.48%
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 5
Forward Annual Dividend Yield 4 0.74%
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 0.87
Payout Ratio 4 55.56%
Dividend Date 3 --
Ex-Dividend Date 4 9/6/2024
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending

Related Tickers